Navigation Links
Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
Date:5/13/2008

- LUVOX(R) CR Approved and Launched

- Screening Closed in First Phase III Fibromyalgia Clinical Trial

PALO ALTO, Calif., May 13 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced financial results for the quarter ended March 31, 2008.

Total revenues for the quarter ended March 31, 2008 were $14.6 million, compared to $14.1 million for the quarter ended March 31, 2007. XYREM(R) (sodium oxybate oral solution) net sales for the first quarter of 2008 increased 32 percent to $11.3 million, compared with $8.6 million for the first quarter of 2007.

Once-Daily LUVOX CR(R) (fluvoxamine maleate) Extended-Release Capsules was approved by the U.S. Food and Drug Administration (FDA) on February 28, 2008 for the treatment of both obsessive compulsive disorder (OCD) and social anxiety disorder (SAD), and the product was shipped to wholesalers late in the first quarter.

"The launch of LUVOX CR in the U.S. is progressing very well," said Robert Myers, President of Jazz Pharmaceuticals. "Our commercial team is focused on introducing this important new treatment option to physicians for their patients with OCD and SAD."

"We are off to a great start in 2008, with significant product development achievements in addition to our commercial success," said Samuel Saks, M.D., Chief Executive Officer. "We recently completed screening of subjects in the first of our Phase III pivotal studies of JZP-6 for the treatment of fibromyalgia syndrome, a key milestone in this program. We look forward to obtaining results from this Phase III trial in the fourth quarter of 2008."

Research and development expenses for the first quarter of 2008 were $21.2 million, compared to $14.9
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Medimetriks Pharmaceuticals, Inc. Begins Operations
2. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
3. Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
4. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2008 Financial Results on Monday, May 12, at 8:30 A.M. EDT
5. Jazz Pharmaceuticals, Inc. to Announce First Quarter Results on May 13, 2008
6. Aida Pharmaceuticals, Inc. Announces Update on Progress of Rh-Apo2L Testing
7. Aida Pharmaceuticals, Inc. Announces Completion of Research Institute Acquisition
8. GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in Sirtuin Research and Development
9. Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R)
10. Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
11. Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... -- DSM Pharmaceutical Products today announced th...ix, Saint Jean D,Illac, France, where DSM will be ...er for Galenix commercial products on a global bas...ness development opportunities co-marketing Galeni...h of Galenix in drug product development and clini...
(Date:11/5/2009)...swire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: ...for processing and storing adult stem cells, today...2010. ,, For the quarter ended September 30, 20... a 15 percent increase over revenues of $4.5 milli...id the key contributors to the growth in revenues ...
(Date:11/5/2009)...Call/ -- Transgenomic, Inc. (OTC Bulletin Board: T...rter ended September 30, 2009. The Company,s finan...ow. ,, Third Quarter 2009 ,, The Company r...for the third quarter of 2009 as compared to a net... quarter of 2008. ,, Net sales were $5.0 milli...
(Date:11/5/2009)...-FirstCall/ -- Cepheid (Nasdaq: CPHD ) today anno...following investor conferences, and invited invest... Credit Suisse Healthcare Conference, Phoenix, AZ...0 a.m. Mountain Time, NASDAQ OMX ... Tuesday, 1 December, 2009 at 10.45 a.m. Gree...
Breaking Biology Technology:DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7Cepheid to Webcast Upcoming Financial Presentations 2
...rd Wave Technologies this week reported the best ...story, wrapping up a year in which it met or excee...d Wave reported total revenues of $46.5 million an...cember 31, compared to total revenues of $36.3 mil...The company reported total revenues of $8.1 millio...
...r community when power stands still? , ,A. Things... wag; its always someone elses fault. , ,C. Young...wn initiative. , ,If you answered "C," you might ...r for the first time in our companys seven year hi.... Unwilling to wait for their communitys tradition...
...usiness. Whoa! Put down those pitchforks and torc...start some kind of technology for technology,s sak... people who are in the business of building and se...er, in the last twenty or so years as wave after w...orld, it became easy, accepted and even fashionabl...
Other Biology Technology:Third Wave boosts numbers in latest report 2Third Wave boosts numbers in latest report 3Third Wave boosts numbers in latest report 4Lead, follow or get out of the way 2Stay in the driver's seat, but don't ditch technology 2Stay in the driver's seat, but don't ditch technology 3
(Date:11/8/2009)...earchers at Purdue University have discovered a ne...pinal cord injuries using nano-spheres that could ...nt. , The synthetic "copolymer micelles" are dru..., or roughly 100 times smaller than the diameter o...ying how to deliver drugs for cancer treatment and...
(Date:11/8/2009)... FOR ADULTS WITH INTELLECTUAL DISABILITIES: AN OPP...rsity study involving adults with intellectual dis...rsonal health knowledge after taking a semi-weekly...ernationally accepted term for mental retardation,...nactivity and preventable chronic diseases compare...
(Date:11/6/2009)...rsary this month of the publication of On the Orig...l Sciences (AIBS) is publishing open access two pe...historic insights into evolution. , The two artic...ornia, Berkeley, and James T. Costa of Western Car...ut Charles Darwin," appeared in the October issue ...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Many Childhood Cancer Survivors Never Marry 59131 1Many Childhood Cancer Survivors Never Marry 59131 2Swine Flu 28H1N1 29 Virus Destroyed by Innovative Air Treatment Technology 59127 1Swine Flu 28H1N1 29 Virus Destroyed by Innovative Air Treatment Technology 59127 2ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 1ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 2ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 3ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 4
...ientists has used gene therapy in two separate stu...ents in monkeys and rats with a drug-induced form ...online in the scientific publications Brain and Th...ne strategy to halt Parkinson,s disease at its ons...ide effects that occur when treating the disease i...
... reveal how an,evolutionary innovation involving t...ven rise to a deep-seated dependency between them ...new work illustrates how genetic exchange through ... a system of interdependence at a,high level of bi...on of,worker ants for both species. , Millions,of ...
...he journal Nature that the "missing" genes for tRN...ogether sequences in distant parts of the DNA geno...n the Department of Molecular Biophysics and Bioch...sm with a known genome sequence. Nanoarchaeum equi... the Archaea containing organisms that are primiti...
Other Biology News:Gene Therapy For Parkinson's Disease Moves Forward In Animals 2Gene Therapy For Parkinson's Disease Moves Forward In Animals 3Gene Therapy For Parkinson's Disease Moves Forward In Animals 4Ants Genetic Engineering Leads To Species Interdependency 2Researchers find missing genes of ancient organism 2
...rs combine high durability and capacity with unequ...nced heavy-duty mechanism prevents vibration, allo...alance loads. Every other part, from the large rub...chined aluminum platform is designed to last throu...
RapidStak 2 (requires 4 staks, not included) from Thermo Scientific
Small bottle, 150 x 35mm from Thermo Scientific
Extra large bottle, 300 x 70mm from Thermo Scientific
Biology Products: